Fjarde Ap-fonden’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,029
Closed -$931K 550
2022
Q3
$931K Hold
28,029
0.01% 534
2022
Q2
$931K Sell
28,029
-12,400
-31% -$527K 0.01% 534
2022
Q1
$2.92M Sell
40,429
-9,100
-18% -$656K 0.03% 494
2021
Q4
$4.55M Buy
49,529
+3,629
+8% +$434K 0.04% 427
2021
Q3
$5.82M Sell
45,900
-200
-0.4% -$29.1K 0.05% 351
2021
Q2
$7.67M Buy
46,100
+4,400
+11% +$713K 0.07% 283
2021
Q1
$7.58M Buy
41,700
+2,200
+6% +$510K 0.07% 283
2020
Q4
$7.9M Buy
39,500
+13,500
+52% +$2.75M 0.07% 249
2020
Q3
$5.7M Buy
26,000
+600
+2% +$127K 0.06% 298
2020
Q2
$4.85M Buy
+25,400
New +$4.45M 0.06% 317

Other funds holding TDOC

Fjarde Ap-fonden's TDOC Position: Q4 2022 in Review

Fjarde Ap-fonden sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 28,029 shares — an estimated $931K sold.

Fjarde Ap-fonden first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $7.9M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Fjarde Ap-fonden reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Fjarde Ap-fonden sold 28,029 Teladoc Health shares in Q4 2022, an estimated $931K.
  • Fjarde Ap-fonden first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Fjarde Ap-fonden's Teladoc Health position peaked at $7.9M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Fjarde Ap-fonden's 13F filing for Q4 2022, filed 14 Feb 2023.